CTIS2024-511411-25-00Active, not recruitingPhase 1
Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated with Variants in the RPGR gene - MGT-RPGR-022
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Janssen Cilag International
- Enrollment
- 95
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 0 to 64 (—)
- Sex
- All
Inclusion Criteria
- •1.Previously completed participation in Study MGT-RPGR-021., 2.Must reconfirm that he or she understands the purpose of, and procedures required for, the study and is willing to participate in the study.
Exclusion Criteria
- •There are no specific exclusion criteria.
Investigators
Similar Trials
Active, not recruiting
Phase 1
ong Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defect on Chromosome X.X-Linked Retinitis Pigmentosa caused by mutations in the RPGR geneMedDRA version: 20.0Level: PTClassification code 10038914Term: Retinitis pigmentosaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-002255-37-BEJanssen-Cilag International NV96
Active, not recruiting
Phase 1
ong Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defect on Chromosome X.X-Linked Retinitis Pigmentosa caused by mutations in the RPGR geneMedDRA version: 20.0Level: PTClassification code 10038914Term: Retinitis pigmentosaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-002255-37-DEMeiraGTx UK II Limited96
Active, not recruiting
Phase 1
ong Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defect on Chromosome X.X-Linked Retinitis Pigmentosa caused by mutations in the RPGR geneMedDRA version: 20.0Level: PTClassification code 10038914Term: Retinitis pigmentosaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-002255-37-Outside-EU/EEAMeiraGTx UK II Limited
Recruiting
Phase 3
Long Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defect on Chromosome X.2024-511411-25-00Janssen Cilag International31
Active, not recruiting
Phase 1
ong Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defect on Chromosome X.X-Linked Retinitis Pigmentosa caused by mutations in the RPGR geneMedDRA version: 20.0Level: PTClassification code 10038914Term: Retinitis pigmentosaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-002255-37-DKJanssen-Cilag International NV96